Wednesday, April 07, 2021 3:47:32 PM
What do you mean by that?
If the 11th Circuit overturns the ruling then it will be punted back to the state supreme court for retrial. Do you see something different? USRM still needs to establish treatment efficacy for SVF. They need to point out that the procedures they perform (tissue harvesting and reimplantation) using SVF technique should be within the same category as "other" autologous SSP tissue transplant procedures which do not come under FDA oversight.
I would expect the 11th Circuit would want expert testimony from both sides. This would require retrial $$$. I do agree that a longer wait time might be an indicator for RR. We will see.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM